Hua-Jun Feng, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, GABA-A | 15 | 2017 | 624 | 2.650 |
Why?
|
| Death, Sudden | 5 | 2017 | 301 | 2.310 |
Why?
|
| Protein Subunits | 8 | 2017 | 940 | 1.160 |
Why?
|
| Seizures | 8 | 2017 | 2996 | 1.100 |
Why?
|
| Respiration Disorders | 3 | 2017 | 364 | 0.970 |
Why?
|
| Epilepsy, Reflex | 4 | 2015 | 25 | 0.910 |
Why?
|
| Mice, Inbred DBA | 7 | 2017 | 624 | 0.870 |
Why?
|
| Etomidate | 2 | 2015 | 185 | 0.800 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2017 | 186 | 0.650 |
Why?
|
| Anesthetics, General | 2 | 2017 | 151 | 0.620 |
Why?
|
| Patch-Clamp Techniques | 9 | 2015 | 924 | 0.580 |
Why?
|
| Respiratory System Agents | 1 | 2017 | 30 | 0.580 |
Why?
|
| Respiratory Insufficiency | 2 | 2017 | 1240 | 0.580 |
Why?
|
| Fluoxetine | 3 | 2016 | 733 | 0.560 |
Why?
|
| Serotonin 5-HT3 Receptor Agonists | 1 | 2016 | 1 | 0.560 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2016 | 23 | 0.550 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2016 | 33 | 0.540 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2016 | 45 | 0.540 |
Why?
|
| Amygdala | 5 | 2008 | 1375 | 0.540 |
Why?
|
| Brugada Syndrome | 1 | 2017 | 98 | 0.520 |
Why?
|
| Acoustic Stimulation | 8 | 2017 | 1253 | 0.510 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2015 | 1139 | 0.500 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2014 | 86 | 0.500 |
Why?
|
| GABA Agents | 1 | 2015 | 41 | 0.500 |
Why?
|
| Membrane Potentials | 4 | 2016 | 1085 | 0.490 |
Why?
|
| Alcohol Withdrawal Seizures | 2 | 2008 | 10 | 0.490 |
Why?
|
| Ion Channel Gating | 3 | 2008 | 428 | 0.480 |
Why?
|
| Epilepsy | 6 | 2017 | 3317 | 0.470 |
Why?
|
| Norepinephrine | 1 | 2017 | 898 | 0.470 |
Why?
|
| Serotonin | 2 | 2017 | 1045 | 0.460 |
Why?
|
| Epilepsy, Generalized | 3 | 2006 | 181 | 0.450 |
Why?
|
| Respiration | 2 | 2017 | 1655 | 0.440 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 374 | 0.420 |
Why?
|
| Disease Models, Animal | 10 | 2017 | 18330 | 0.380 |
Why?
|
| Receptors, GABA | 2 | 2016 | 312 | 0.370 |
Why?
|
| Photic Stimulation | 1 | 2017 | 1989 | 0.370 |
Why?
|
| Synaptic Transmission | 3 | 2015 | 1175 | 0.350 |
Why?
|
| Barbiturates | 1 | 2010 | 113 | 0.340 |
Why?
|
| Anticonvulsants | 2 | 2017 | 1921 | 0.320 |
Why?
|
| Pentobarbital | 2 | 2010 | 153 | 0.310 |
Why?
|
| Action Potentials | 2 | 2008 | 1835 | 0.290 |
Why?
|
| Central Nervous System Depressants | 1 | 2008 | 163 | 0.280 |
Why?
|
| GABA Modulators | 2 | 2004 | 108 | 0.280 |
Why?
|
| Kindling, Neurologic | 3 | 2003 | 24 | 0.260 |
Why?
|
| Lasers | 1 | 2010 | 951 | 0.260 |
Why?
|
| Penicillins | 1 | 2008 | 404 | 0.240 |
Why?
|
| Models, Molecular | 1 | 2014 | 5388 | 0.220 |
Why?
|
| Neuronal Plasticity | 2 | 2002 | 1446 | 0.220 |
Why?
|
| Status Epilepticus | 1 | 2008 | 459 | 0.200 |
Why?
|
| Rats | 10 | 2014 | 23713 | 0.200 |
Why?
|
| Histamine | 2 | 2001 | 496 | 0.190 |
Why?
|
| Ethanol | 1 | 2008 | 1330 | 0.190 |
Why?
|
| Neurons | 4 | 2010 | 9517 | 0.190 |
Why?
|
| Point Mutation | 2 | 2004 | 1591 | 0.190 |
Why?
|
| Geniculate Bodies | 1 | 2002 | 157 | 0.190 |
Why?
|
| Allosteric Regulation | 3 | 2014 | 424 | 0.180 |
Why?
|
| Animals | 18 | 2017 | 168965 | 0.180 |
Why?
|
| Inhibitory Postsynaptic Potentials | 3 | 2010 | 62 | 0.180 |
Why?
|
| 2-Chloroadenosine | 1 | 2000 | 11 | 0.180 |
Why?
|
| Synapses | 2 | 2017 | 1759 | 0.180 |
Why?
|
| Brain Stem | 2 | 2016 | 858 | 0.180 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6507 | 0.170 |
Why?
|
| Inferior Colliculi | 1 | 2000 | 79 | 0.160 |
Why?
|
| Protons | 1 | 2004 | 1101 | 0.160 |
Why?
|
| Electrophysiology | 3 | 2008 | 1263 | 0.150 |
Why?
|
| Propofol | 1 | 2004 | 608 | 0.150 |
Why?
|
| Antibiotics, Antitubercular | 1 | 1998 | 100 | 0.140 |
Why?
|
| Serotonin Agents | 1 | 2016 | 29 | 0.140 |
Why?
|
| Cell Line | 7 | 2010 | 15567 | 0.140 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1998 | 246 | 0.130 |
Why?
|
| Mixed Function Oxygenases | 1 | 1998 | 265 | 0.130 |
Why?
|
| Pentylenetetrazole | 1 | 2016 | 72 | 0.130 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2016 | 93 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2016 | 10748 | 0.130 |
Why?
|
| Rifampin | 1 | 1998 | 350 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1998 | 423 | 0.120 |
Why?
|
| Mice | 6 | 2017 | 81912 | 0.120 |
Why?
|
| Diazepam | 2 | 2008 | 215 | 0.120 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2016 | 256 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2008 | 8108 | 0.120 |
Why?
|
| Receptors, Serotonin | 1 | 2015 | 210 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2010 | 451 | 0.110 |
Why?
|
| Drug Partial Agonism | 1 | 2014 | 24 | 0.110 |
Why?
|
| Transfection | 3 | 2008 | 5753 | 0.110 |
Why?
|
| Kinetics | 3 | 2006 | 6287 | 0.100 |
Why?
|
| Rats, Mutant Strains | 2 | 2002 | 60 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 396 | 0.100 |
Why?
|
| Xenopus | 1 | 2014 | 710 | 0.100 |
Why?
|
| Species Specificity | 1 | 2016 | 2412 | 0.100 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 1676 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 849 | 0.090 |
Why?
|
| Phosphinic Acids | 1 | 2010 | 17 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2010 | 55 | 0.090 |
Why?
|
| Myoclonic Epilepsy, Juvenile | 1 | 2010 | 13 | 0.090 |
Why?
|
| Bicuculline | 1 | 2010 | 96 | 0.090 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2010 | 59 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 1743 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2008 | 1736 | 0.090 |
Why?
|
| Allosteric Site | 1 | 2010 | 106 | 0.090 |
Why?
|
| Ions | 1 | 2010 | 254 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 11923 | 0.080 |
Why?
|
| Benzylamines | 1 | 2010 | 251 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2016 | 4280 | 0.080 |
Why?
|
| Binding Sites | 1 | 2017 | 6014 | 0.080 |
Why?
|
| Biophysics | 1 | 2010 | 376 | 0.080 |
Why?
|
| Oocytes | 1 | 2014 | 1168 | 0.080 |
Why?
|
| Valine | 1 | 2010 | 410 | 0.080 |
Why?
|
| Psychoacoustics | 1 | 2008 | 59 | 0.080 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 876 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 22361 | 0.080 |
Why?
|
| Pilocarpine | 1 | 2008 | 64 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 861 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2010 | 1989 | 0.070 |
Why?
|
| Heart Rate | 1 | 2017 | 4209 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2006 | 405 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9551 | 0.060 |
Why?
|
| Lithium | 1 | 2008 | 600 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 661 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2014 | 3642 | 0.060 |
Why?
|
| Amino Acids, Basic | 1 | 2003 | 9 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1314 | 0.060 |
Why?
|
| Zinc | 1 | 2008 | 675 | 0.050 |
Why?
|
| Temperature | 1 | 2010 | 2232 | 0.050 |
Why?
|
| Microinjections | 2 | 2003 | 319 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3760 | 0.050 |
Why?
|
| Rats, Inbred Strains | 2 | 2003 | 2078 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2016 | 6409 | 0.050 |
Why?
|
| Behavior, Animal | 2 | 2008 | 1865 | 0.050 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2008 | 789 | 0.050 |
Why?
|
| Humans | 17 | 2017 | 767040 | 0.050 |
Why?
|
| Receptors, Histamine | 1 | 2001 | 23 | 0.050 |
Why?
|
| Muscimol | 1 | 2001 | 70 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2006 | 18063 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2010 | 18989 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2008 | 1137 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8531 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2001 | 106 | 0.050 |
Why?
|
| Male | 9 | 2017 | 364203 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 4401 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2592 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2000 | 39 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2003 | 431 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2478 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2003 | 1419 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2014 | 12793 | 0.040 |
Why?
|
| Kidney | 2 | 2004 | 7063 | 0.040 |
Why?
|
| Mephenytoin | 1 | 1998 | 3 | 0.040 |
Why?
|
| Hydroxylation | 1 | 1998 | 139 | 0.040 |
Why?
|
| Female | 7 | 2017 | 396660 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2003 | 1182 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 455 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2212 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 1998 | 612 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2004 | 1422 | 0.030 |
Why?
|
| Hippocampus | 1 | 2008 | 3777 | 0.030 |
Why?
|
| Mutation | 2 | 2004 | 30211 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5754 | 0.030 |
Why?
|
| Models, Biological | 1 | 2008 | 9464 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2002 | 3078 | 0.020 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2010 | 17 | 0.020 |
Why?
|
| Neurochemistry | 1 | 2008 | 29 | 0.020 |
Why?
|
| Electronics, Medical | 1 | 2008 | 70 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 30238 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 299 | 0.020 |
Why?
|
| Time Factors | 2 | 2008 | 40154 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5891 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2008 | 589 | 0.010 |
Why?
|
| Protein Transport | 1 | 2010 | 1944 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 2004 | 88 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 1132 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 231 | 0.010 |
Why?
|
| Seizures, Febrile | 1 | 2004 | 109 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 2815 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 1774 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 2794 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 4539 | 0.010 |
Why?
|
| Adult | 1 | 1998 | 223317 | 0.000 |
Why?
|